『This Moment In Medicine: First-Line HER2+ Metastatic Breast Cancer with Dr. Mothaffar Rimawi』のカバーアート

This Moment In Medicine: First-Line HER2+ Metastatic Breast Cancer with Dr. Mothaffar Rimawi

This Moment In Medicine: First-Line HER2+ Metastatic Breast Cancer with Dr. Mothaffar Rimawi

無料で聴く

ポッドキャストの詳細を見る

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり

How should we approach first-line treatment as the HER2-positive metastatic breast cancer landscape rapidly evolves?


At This Moment in Medicine, hosted by Community Health Media, Dr. Mothaffar Rimawi examines how new data are reshaping a treatment landscape long defined by the CLEOPATRA regimen.


From DESTINY-Breast09 to PATINA and HER2CLIMB-05, Dr. Rimawi explores emerging strategies for deeper HER2 and ER pathway inhibition, the role of T-DXd, and how clinicians might individualize treatment based on disease biology, burden, toxicity, and patient preference.


Topics discussed:

  • The evolution of first-line HER2-positive metastatic breast cancer treatment
  • CLEOPATRA and the foundation of modern HER2-directed therapy
  • PATINA and the addition of palbociclib in HR+/HER2+ disease
  • DESTINY-Breast09 and T-DXd plus pertuzumab
  • Depth and duration of response with T-DXd
  • HER2CLIMB-05 and tucatinib maintenance
  • ILD, transaminitis, and other treatment-related toxicities
  • Patient-reported outcomes and quality of life
  • Selecting treatment based on ER status, CNS disease, disease burden, and molecular profile
  • T-DXd duration and the possibility of induction-maintenance strategies
  • How PATINA and HER2CLIMB-05 could inform maintenance therapy

The presentation concludes with a panel discussion addressing a critical question for the field: With several highly effective strategies now available, how do we choose the right first-line approach for the right patient?


▶️ Watch more from This Moment in Medicine and subscribe to Community Health Media for expert conversations on the latest advances shaping cancer care.

🎧 Subscribe for the latest insights from leading cancer specialists.


#ThisMomentInMedicine #MothaffarRimawi #HER2Positive #MetastaticBreastCancer #DESTINYBreast09 #TDXd #PATINA #HER2CLIMB05 #BreastOncology #MedicalOncology #CommunityHealthMedia

–


Thanks for watching!


Our podcasts are also available on:

• Spotify - https://spotf.fi/chm-podcast

• Amazon Music - https://amazn.so/chm-podcast

• Apple Podcast - https://podcasts.apple.com/us/podcast/community-health-media/id1837428248

• Castbox - https://castbox.fm/vh/6735434

• Goodpods - https://goodpods.com/profile/chm-111066

• iHeartRadio - https://iheart.com/podcast/291542082

• Pocket Casts - https://pca.st/3ncdh11o


–


Community Health Media (CHM) is your full service healthcare communications partner, combining our production expertise with targeted multi-channel campaigns. We connect companies and healthcare brands with key opinion leaders, patients, and consumers through compelling content and live experiences.


We’re an integrated marketing company that produces world-class content and curated peer to peer live experiences.


We specialize in:

• Peer to peer interviews, panels & round-tables

• Curated live events & conferences

• Professional in-depth content & research updates

• Interactive learning modules & webinars

• Live & on-demand webcasts & podcasts


Learn more about us here - https://communityhealth.media

adbl_web_anon_alc_button_suppression_t1
まだレビューはありません